rs143153487

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_000100.4(CSTB):​c.121G>A​(p.Val41Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00168 in 1,614,132 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00098 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0017 ( 1 hom. )

Consequence

CSTB
NM_000100.4 missense

Scores

2
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:8

Conservation

PhyloP100: -0.286

Publications

8 publications found
Variant links:
Genes affected
CSTB (HGNC:2482): (cystatin B) The cystatin superfamily encompasses proteins that contain multiple cystatin-like sequences. Some of the members are active cysteine protease inhibitors, while others have lost or perhaps never acquired this inhibitory activity. There are three inhibitory families in the superfamily, including the type 1 cystatins (stefins), type 2 cystatins and kininogens. This gene encodes a stefin that functions as an intracellular thiol protease inhibitor. The protein is able to form a dimer stabilized by noncovalent forces, inhibiting papain and cathepsins l, h and b. The protein is thought to play a role in protecting against the proteases leaking from lysosomes. Evidence indicates that mutations in this gene are responsible for the primary defects in patients with progressive myoclonic epilepsy (EPM1). One type of mutation responsible for EPM1 is the expansion in the promoter region of this gene of a CCCCGCCCCGCG repeat from 2-3 copies to 30-78 copies. [provided by RefSeq, Jul 2016]
CSTB Gene-Disease associations (from GenCC):
  • Unverricht-Lundborg syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, ClinGen, Labcorp Genetics (formerly Invitae)
  • genetic developmental and epileptic encephalopathy
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen
  • autosomal recessive hypohidrotic ectodermal dysplasia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.017322361).
BP6
Variant 21-43774705-C-T is Benign according to our data. Variant chr21-43774705-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 195015.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000985 (150/152330) while in subpopulation SAS AF = 0.00228 (11/4826). AF 95% confidence interval is 0.00152. There are 0 homozygotes in GnomAd4. There are 71 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000100.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CSTB
NM_000100.4
MANE Select
c.121G>Ap.Val41Met
missense
Exon 2 of 3NP_000091.1Q76LA1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CSTB
ENST00000291568.7
TSL:1 MANE Select
c.121G>Ap.Val41Met
missense
Exon 2 of 3ENSP00000291568.6P04080
CSTB
ENST00000896953.1
c.109G>Ap.Val37Met
missense
Exon 2 of 3ENSP00000567012.1
CSTB
ENST00000937601.1
c.121G>Ap.Val41Met
missense
Exon 2 of 3ENSP00000607660.1

Frequencies

GnomAD3 genomes
AF:
0.000979
AC:
149
AN:
152212
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00207
Gnomad FIN
AF:
0.000659
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00178
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.00119
AC:
300
AN:
251478
AF XY:
0.00128
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.000549
Gnomad ASJ exome
AF:
0.000298
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000878
Gnomad NFE exome
AF:
0.00171
Gnomad OTH exome
AF:
0.000977
GnomAD4 exome
AF:
0.00175
AC:
2556
AN:
1461802
Hom.:
1
Cov.:
30
AF XY:
0.00176
AC XY:
1278
AN XY:
727208
show subpopulations
African (AFR)
AF:
0.000179
AC:
6
AN:
33480
American (AMR)
AF:
0.000470
AC:
21
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000344
AC:
9
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.00167
AC:
144
AN:
86256
European-Finnish (FIN)
AF:
0.00129
AC:
69
AN:
53400
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.00200
AC:
2228
AN:
1111944
Other (OTH)
AF:
0.00127
AC:
77
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
142
284
427
569
711
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
88
176
264
352
440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000985
AC:
150
AN:
152330
Hom.:
0
Cov.:
33
AF XY:
0.000953
AC XY:
71
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.000168
AC:
7
AN:
41572
American (AMR)
AF:
0.000196
AC:
3
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00228
AC:
11
AN:
4826
European-Finnish (FIN)
AF:
0.000659
AC:
7
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00178
AC:
121
AN:
68030
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
8
17
25
34
42
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00137
Hom.:
2
Bravo
AF:
0.000861
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00153
EpiControl
AF:
0.00190

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
2
Unverricht-Lundborg syndrome (3)
-
1
1
not provided (2)
-
-
2
not specified (2)
-
-
1
CSTB-related disorder (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
Progressive myoclonic epilepsy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.099
BayesDel_addAF
Benign
-0.63
T
BayesDel_noAF
Benign
-0.69
CADD
Benign
8.9
DANN
Benign
0.97
DEOGEN2
Benign
0.31
T
Eigen
Benign
-0.72
Eigen_PC
Benign
-0.95
FATHMM_MKL
Benign
0.053
N
LIST_S2
Benign
0.63
T
M_CAP
Benign
0.0049
T
MetaRNN
Benign
0.017
T
MetaSVM
Benign
-1.1
T
PhyloP100
-0.29
PrimateAI
Uncertain
0.50
T
PROVEAN
Benign
-2.0
N
REVEL
Benign
0.094
Sift
Benign
0.030
D
Sift4G
Uncertain
0.041
D
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.15
gMVP
0.28
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs143153487; hg19: chr21-45194586; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.